Results for
"[search-keyword]"
Sponsor content
165 result(s) found, displaying 61 to 70
-
Prescription medicine decision summaryTGA decision: Sogroya (somapacitan) is approved to treat adults with growth hormone deficiency (AGHD).
-
Prescription medicine decision summaryTGA decision: Rybelsus (semaglutide) is approved to treat type 2 diabetes mellitus
-
Prescription medicine registrationActive ingredients: somapacitan.
-
Prescription medicine registrationActive ingredients: somapacitan.
-
Prescription medicine registrationActive ingredients: semaglutide.
-
Prescription medicine registrationActive ingredients: semaglutide.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REFIXIA nonacog beta pegol 2000 IU powder and solvent for solution for injection.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REFIXIA nonacog beta pegol 1000 IU powder and solvent for solution for injection.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REFIXIA nonacog beta pegol 500 IU powder and solvent for solution for injection.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen.